DSG Capital Advisors LLC Takes Position in Solventum Co. (NYSE:SOLV)

DSG Capital Advisors LLC purchased a new position in Solventum Co. (NYSE:SOLV - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,956 shares of the company's stock, valued at approximately $261,000.

A number of other hedge funds also recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC increased its position in shares of Solventum by 2.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 48,979 shares of the company's stock worth $3,236,000 after purchasing an additional 1,057 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Solventum during the fourth quarter worth about $3,472,000. GF Fund Management CO. LTD. acquired a new position in shares of Solventum in the fourth quarter valued at approximately $229,000. JT Stratford LLC increased its stake in shares of Solventum by 17.5% in the fourth quarter. JT Stratford LLC now owns 26,692 shares of the company's stock valued at $1,763,000 after buying an additional 3,967 shares during the period. Finally, Ananym Capital Management LP bought a new position in Solventum in the 4th quarter valued at approximately $17,620,000.

Solventum Trading Down 0.0%

Solventum stock traded down $0.01 during mid-day trading on Monday, hitting $73.08. 961,023 shares of the stock were exchanged, compared to its average volume of 1,225,718. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $85.92. The firm's fifty day simple moving average is $69.42 and its two-hundred day simple moving average is $71.36. The stock has a market capitalization of $12.64 billion and a price-to-earnings ratio of 33.83.

Solventum (NYSE:SOLV - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.15. The firm had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.02 billion. During the same quarter in the previous year, the business posted $2.08 EPS. The firm's revenue for the quarter was up 2.7% compared to the same quarter last year. Analysts forecast that Solventum Co. will post 6.58 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently commented on SOLV. Morgan Stanley lifted their target price on shares of Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research report on Wednesday, March 5th. The Goldman Sachs Group lifted their target price on shares of Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a research report on Monday, March 3rd. Piper Sandler upgraded shares of Solventum from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $78.00 to $87.00 in a research report on Monday, May 19th. Wells Fargo & Company lifted their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Finally, Mizuho lifted their target price on shares of Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $80.29.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.